Access to anti-retroviral drugs, male in Ireland

Ireland: Access to anti-retroviral drugs, male was 89.0% in 2023. ▲ Rising

Latest (2023)
89.0%
Change on year
unchanged
World rank
17th
of 141 countries
All-time high
89.0%
in 2022
All-time low
36.0%
in 2000
Years of data
24
2000–2023

Access to anti-retroviral drugs, male in Ireland, 2000–2023

0204060802000201120232000: 36 %2001: 40 %2002: 44 %2003: 47 %2004: 48 %2005: 50 %2006: 50 %2007: 51 %2008: 52 %2009: 53 %2010: 54 %2011: 59 %2012: 63 %2013: 67 %2014: 71 %2015: 75 %2016: 78 %2017: 81 %2018: 82 %2019: 84 %2020: 86 %2021: 86 %2022: 89 %2023: 89 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Ireland is 89.0%, measured in 2023. That is the highest value across all 24 years on record.

Compared with earlier readings it is up 32.8% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Ireland peaked at 89.0% in 2022 and was at its lowest, 36.0%, in 2000.

Ireland ranks 17th of 141 countries on this measure, in the top quarter.

The long-run direction has been consistently rising across the 24 years of available data.

Access to anti-retroviral drugs, male in Ireland, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Ireland, 2000 to 2023.
Year % Change
2000 36.0%
2001 40.0% +11.1%
2002 44.0% +10.0%
2003 47.0% +6.8%
2004 48.0% +2.1%
2005 50.0% +4.2%
2006 50.0% +0.0%
2007 51.0% +2.0%
2008 52.0% +2.0%
2009 53.0% +1.9%
2010 54.0% +1.9%
2011 59.0% +9.3%
2012 63.0% +6.8%
2013 67.0% +6.3%
2014 71.0% +6.0%
2015 75.0% +5.6%
2016 78.0% +4.0%
2017 81.0% +3.8%
2018 82.0% +1.2%
2019 84.0% +2.4%
2020 86.0% +2.4%
2021 86.0% +0.0%
2022 89.0% +3.5%
2023 89.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 47.1% 36.0% 53.0% 10
2010s 71.4% 54.0% 84.0% 10
2020s 87.5% 86.0% 89.0% 4

Countries ranked near Ireland

  1. 17 France 89.0% compare
  2. 17 Iceland 89.0% compare
  3. 17 Netherlands 89.0% compare
  4. 17 Romania 89.0% compare
  5. 17 Zimbabwe 89.0% compare

See the full ranking of 160 places →

More gender data for Ireland

All data for Ireland →

Frequently asked questions

What is access to anti-retroviral drugs, male in Ireland?
Access to anti-retroviral drugs, male in Ireland was 89.0% in 2023, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Ireland?
The highest recorded value was 89.0% in 2022.
What is the lowest access to anti-retroviral drugs, male recorded in Ireland?
The lowest recorded value was 36.0% in 2000.
How does Ireland rank for access to anti-retroviral drugs, male?
Ireland ranks 17th out of 141 countries with data for 2023.
Is access to anti-retroviral drugs, male rising or falling in Ireland?
Over the last ten years it is up 32.8%. The long-run trend across the full record is rising.
Where does this Ireland data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Ireland. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ireland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/ireland/">Access to anti-retroviral drugs, male in Ireland</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.